About
Poold Diagnostics is developing a high-throughput diagnostic testing method for SARS-CoV-2 diagnostic screens. The companys pooled testing method allows diagnostic laboratories to increase their testing capacity by up to a factor of 20x using their existing diagnostic testing setup. The novel method identifies all positive subjects within a large set of samples using a single round of testing, thereby reducing test costs while increasing testing capacity. The companys pooling-based efficient SARS-CoV-2 testing (P-BEST) method uses PCR together with a combinatorial pooling algorithm based on the mathematical theory of compressed sensing. The method, which was recently approved for clinical use by the Israeli Ministry of Health, has been used to screen over 5,000 subjects using only 700 pools and has correctly detected more than 60 positive carriers with no false negatives. P-BEST was developed by a group of researchers from Ben-Gurion University of the Negev, the National Institute for Biotechnology in the Negev and The Open University of Israel. A study describing P-BEST was simultaneously published in August 2020 in the journal Science Advances and featured in a New York Times article. The method was also covered by Scientific American, Haaretz, the BBC, and other outlets.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Poold Diagnostics' primary focus?
- Poold Diagnostics is developing a high-throughput diagnostic testing method for SARS-CoV-2 diagnostic screens, utilizing a pooled testing method to increase testing capacity.
- What is the status of Poold Diagnostics as of January 2023?
- As of January 2023, Poold Diagnostics is inactive and has ceased to operate.
- When was Poold Diagnostics founded?
- Poold Diagnostics was founded in July 2020.
- What is the name of Poold Diagnostics' core testing method?
- Poold Diagnostics' core testing method is called P-BEST (pooling-based efficient SARS-CoV-2 testing).
- Which Israeli authority approved Poold Diagnostics' P-BEST method for clinical use?
- The Israeli Ministry of Health approved Poold Diagnostics' P-BEST method for clinical use.
- What was the outcome of the P-BEST method's clinical use in screening subjects?
- The P-BEST method screened over 5,000 subjects using 700 pools, correctly detecting more than 60 positive carriers with no false negatives.
- Which institutions developed the P-BEST method?
- P-BEST was developed by researchers from Ben-Gurion University of the Negev, the National Institute for Biotechnology in the Negev, and The Open University of Israel.
- When was a study describing P-BEST published, and in which journal?
- A study describing P-BEST was simultaneously published in August 2020 in the journal Science Advances.
- How many employees did Poold Diagnostics have?
- Poold Diagnostics had 3 employees.